Tasigna (nilotinib) is a cancer drug used to treat Philadelphia chromosome-positive chronic myeloid leukemia. Tasigna has been linked to atherosclerosis, peripheral arterial disease, amputation, coronary artery disease, stroke, and death. Tasigna causes a deadly condition called atherosclerosis, a thickening of the walls of the arteries, which causes peripheral arterial disease. Tasigna’s narrowing of arteries can lead to infections and tissue death requiring amputation, coronary artery disease, stroke, and death. The public has never been warned of Tasigna atherosclerosis.
Tasigna side effects include irreversible and life threatening conditions that can result in:
Tasigna is approved to treat Acute lymphocytic leukemia (ALL), also called acute lymphoblastic leukemia. Acute lymphocytic leukemia is a cancer that starts from the early version of white blood cells called lymphocytes in the bone marrow (the soft inner part of the bones, where new blood cells are made).
Atherosclerosis is a condition that causes the artery walls to thicken. The thickening is caused by a buildup of white blood cells and the growth of a fibrofatty plaque.
When the arterial walls thicken, the channel where blood flows becomes narrowed. This condition is known as peripheral arterial disease (PAD). PAD most commonly affects the legs, but can also occur in other arteries. The lack of proper blood circulation which occurs as a result of Tasigna atherosclerosis is severe and irreversible, causes infections and tissue death, and may require one or more limb amputations. Coronary artery disease, stroke, and death are all possible outcomes of Tasigna atherosclerosis.
Did you or a loved one suffer atherosclerosis, artery disease, amputation, stroke and death after or while using the drug Tasigna?
Find out if you may qualify for compensation.Find Out More
Consumer Safety Watch offers safety advocate services and attorney referral services for patients throughout the United States including the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
Consumer Safety Watch offers consumer safety advocate services or can help you find an attorney throughout the United States including the following cities: Albuquerque, NM; Arlington, TX; Atlanta, GA; Austin, TX; Baltimore, MD; Boston, MA; Charlotte, NC; Chicago, IL; Cleveland, OH; Colorado Springs, CO; Columbus, OH; Dallas, TX; Denver, CO; Detroit, MI; Fresno, CA; Fort Worth, TX; Indianapolis, IN; Honolulu, HI; Houston, TX; Jacksonville, FL; Kansas City, KS; Kansas City, MO; Las Vegas, NV; Long Beach, CA; Los Angeles, CA; Louisville, KY; Memphis, TN; Mesa, AZ; Miami, FL; Miami, OH; Milwaukee, WI; Minneapolis, MN; Nashville, TN; New York City, NY; Oakland, CA; Oklahoma City, OK; Omaha, NE; Philadelphia, PA; Phoenix, AZ; Pittsburgh, PA; Portland, OR; Sacramento, CA; San Antonio, Tx; San Diego, CA; San Francisco, CA; San Jose, CA; Seattle, WA; St. Louis, MO; Tampa, FL; Tucson, AZ; Tulsa, Virginia Beach, VA; Washington, DC; Wichita, KS.
This website is not affiliated with any pharmaceutical or medical device company or any trademarked product. Results are not guaranteed. This website provides a free matching service and is not responsible for information or services from third party providers. Consumer Safety Watch is not a law firm. Every case is different and services available can vary.